No Data
No Data
A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $183
Cautious Outlook on Veeva Systems Amidst Rising Competition and Customer Concerns
Customer attrition has led to a decline in Veeva (VEEV.US) stock prices. Baird reassures the market: the financial impact is manageable and maintains a "Shareholding" rating.
An executive from Veeva Systems, a Global provider of cloud solutions for the life sciences Industry, stated that a customer switched to Salesforce, causing the stock to drop by about 5% on Wednesday and eliciting reactions from Analysts.
Veeva Dips After Customer Chooses Salesforce, Baird Sees Ramifications Manageable
Results: Veeva Systems Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
No Data